BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

661 related articles for article (PubMed ID: 35365796)

  • 1. B cells and tertiary lymphoid structures as determinants of tumour immune contexture and clinical outcome.
    Fridman WH; Meylan M; Petitprez F; Sun CM; Italiano A; Sautès-Fridman C
    Nat Rev Clin Oncol; 2022 Jul; 19(7):441-457. PubMed ID: 35365796
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tertiary lymphoid structures in the era of cancer immunotherapy.
    Sautès-Fridman C; Petitprez F; Calderaro J; Fridman WH
    Nat Rev Cancer; 2019 Jun; 19(6):307-325. PubMed ID: 31092904
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tertiary Lymphoid Structures as a Predictive Biomarker of Response to Cancer Immunotherapies.
    Trüb M; Zippelius A
    Front Immunol; 2021; 12():674565. PubMed ID: 34054861
    [TBL] [Abstract][Full Text] [Related]  

  • 4. STINGing the Tumor Microenvironment to Promote Therapeutic Tertiary Lymphoid Structure Development.
    Filderman JN; Appleman M; Chelvanambi M; Taylor JL; Storkus WJ
    Front Immunol; 2021; 12():690105. PubMed ID: 34054879
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of B cells in Tertiary Lymphoid Structures in cancer: Anti-tumor or anti-self?
    Fridman WH; Sibéril S; Pupier G; Soussan S; Sautès-Fridman C
    Semin Immunol; 2023 Jan; 65():101703. PubMed ID: 36481358
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Participation of B cell in immunotherapy of cancer.
    Chandnani N; Gupta I; Mandal A; Sarkar K
    Pathol Res Pract; 2024 Mar; 255():155169. PubMed ID: 38330617
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tertiary lymphoid structures generate and propagate anti-tumor antibody-producing plasma cells in renal cell cancer.
    Meylan M; Petitprez F; Becht E; Bougoüin A; Pupier G; Calvez A; Giglioli I; Verkarre V; Lacroix G; Verneau J; Sun CM; Laurent-Puig P; Vano YA; Elaïdi R; Méjean A; Sanchez-Salas R; Barret E; Cathelineau X; Oudard S; Reynaud CA; de Reyniès A; Sautès-Fridman C; Fridman WH
    Immunity; 2022 Mar; 55(3):527-541.e5. PubMed ID: 35231421
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tertiary lymphoid structural heterogeneity determines tumour immunity and prospects for clinical application.
    Zhang Y; Xu M; Ren Y; Ba Y; Liu S; Zuo A; Xu H; Weng S; Han X; Liu Z
    Mol Cancer; 2024 Apr; 23(1):75. PubMed ID: 38582847
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tertiary lymphoid structures and associated plasma cells play an important role in the biology of triple-negative breast cancers.
    Seow DYB; Yeong JPS; Lim JX; Chia N; Lim JCT; Ong CCH; Tan PH; Iqbal J
    Breast Cancer Res Treat; 2020 Apr; 180(2):369-377. PubMed ID: 32034580
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The prognostic value and molecular properties of tertiary lymphoid structures in oesophageal squamous cell carcinoma.
    Ling Y; Zhong J; Weng Z; Lin G; Liu C; Pan C; Yang H; Wei X; Xie X; Wei X; Zhang H; Wang G; Fu J; Wen J
    Clin Transl Med; 2022 Oct; 12(10):e1074. PubMed ID: 36245289
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Germinal center reactions in tertiary lymphoid structures associate with neoantigen burden, humoral immunity and long-term survivorship in pancreatic cancer.
    J Gunderson A; Rajamanickam V; Bui C; Bernard B; Pucilowska J; Ballesteros-Merino C; Schmidt M; McCarty K; Philips M; Piening B; Dubay C; Medler T; Newell P; Hansen P; Tran E; Tang E; Bifulco C; Crittenden M; Gough M; Young KH
    Oncoimmunology; 2021 Mar; 10(1):1900635. PubMed ID: 33796412
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Standardized Analysis of Tertiary Lymphoid Structures in Human Melanoma: Disease Progression- and Tumor Site-Associated Changes With Germinal Center Alteration.
    Werner F; Wagner C; Simon M; Glatz K; Mertz KD; Läubli H; Griss J; Wagner SN
    Front Immunol; 2021; 12():675146. PubMed ID: 34248957
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tertiary lymphoid structures in cancer: maturation and induction.
    Chen Y; Wu Y; Yan G; Zhang G
    Front Immunol; 2024; 15():1369626. PubMed ID: 38690273
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Tertiary lymphoid structures in cancer: From biology to therapeutic guides].
    Quesada S; Lebreton C; Caux C; Italiano A; Dubois B
    Bull Cancer; 2023 Jun; 110(6):657-664. PubMed ID: 37150731
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting Tertiary Lymphoid Structures for Tumor Immunotherapy.
    Tang H; Qiu X; Timmerman C; Fu YX
    Methods Mol Biol; 2018; 1845():275-286. PubMed ID: 30141019
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dendritic cells in tumor-associated tertiary lymphoid structures signal a Th1 cytotoxic immune contexture and license the positive prognostic value of infiltrating CD8+ T cells.
    Goc J; Germain C; Vo-Bourgais TK; Lupo A; Klein C; Knockaert S; de Chaisemartin L; Ouakrim H; Becht E; Alifano M; Validire P; Remark R; Hammond SA; Cremer I; Damotte D; Fridman WH; Sautès-Fridman C; Dieu-Nosjean MC
    Cancer Res; 2014 Feb; 74(3):705-15. PubMed ID: 24366885
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Manipulation of tumour-infiltrating B cells and tertiary lymphoid structures: a novel anti-cancer treatment avenue?
    Siliņa K; Rulle U; Kalniņa Z; Linē A
    Cancer Immunol Immunother; 2014 Jul; 63(7):643-62. PubMed ID: 24695950
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular, Immunological, and Clinical Features Associated With Lymphoid Neogenesis in Muscle Invasive Bladder Cancer.
    Pagliarulo F; Cheng PF; Brugger L; van Dijk N; van den Heijden M; Levesque MP; Silina K; van den Broek M
    Front Immunol; 2021; 12():793992. PubMed ID: 35145509
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cutaneous Melanoma: Mutational Status and Potential Links to Tertiary Lymphoid Structure Formation.
    Salem D; Chelvanambi M; Storkus WJ; Fecek RJ
    Front Immunol; 2021; 12():629519. PubMed ID: 33746966
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tertiary lymphoid structures and cytokines interconnections: The implication in cancer immunotherapy.
    Li H; Ding JY; Zhang MJ; Yu HJ; Sun ZJ
    Cancer Lett; 2023 Aug; 568():216293. PubMed ID: 37392991
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.